News
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2022 ACCOUNTS
Kaufman & Broad SA: AVAILABILITY OF THE PREPARATORY DOCUMENTS FOR THE COMBINED ORDINARY AND EXTRAORDINARY GENERAL MEETING OF MAY 4, 2023
ALD: Availability of the 2022 Universal Registration Document
EQS-News: Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
MYHOTELMATCH: Approval of the resolutions by the General Meeting of 4 April 2023
BILENDI: 2022 results: Strong increase in profitability
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Kaufman & Broad SA: AVAILABILITY OF THE 2022 UNIVERSAL REGISTRATION DOCUMENT
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus
Transgene Announces Upcoming Investor Meetings
Regulatory News:
TRANSGENE (Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that Management will participate in
Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; Joachim Kreuzburg remains Chairman of the Board
Linedata Confirms Commitment to APAC Region With New Office in Singapore
Linedata (Euronext Paris: LIN), a global provider of credit and asset management technology, data and services, announces today the opening of its new office in Singapore, strengthening its
ESI Group feiert ihr 50-jähriges Jubiläum mit einem klaren Rebranding und schlägt ein neues Kapitel der Unternehmensgeschichte auf
Die ESI Group (ISIN-Code: FR0004110310, Tickersymbol: ESI), der weltweit anerkannte Software-Anbieter für Simulation und Virtual Prototyping für die Industrie, kündigt anlässlich ihres 50-jährigen
ESI Group Reveals Bold Rebranding to Celebrate 50 Years and Marks the Beginning of a Next Chapter
Regulatory News:
ESI Group (ISIN Code: FR0004110310, Symbol: ESI), the world-renowned simulation and virtual prototyping software provider for the industry, announces a dynamic new brand identity
Poxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic
Poxel Reports Financial Results for Full Year 2022 and Provides Corporate Update
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic
Teleperformance Announces Continuation of Full-service Content Moderation
Regulatory News:
Teleperformance (Paris:TEP), a global leader in outsourced digital integrated business services, today announced it will resume offering full-service content moderation services
Poxel will Report its 2022 Full Year Results on March 23, 2023
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic
Neue renommierte wissenschaftliche Publikation von Carbios betont die Ausweitung der Forschungstätigkeit auf weitere Kunststoffe
Carbios (Euronext Growth Paris: ALCRB), ein Pionier in der Entwicklung und Industrialisierung enzymatischer Lösungen für das Recycling von Kunststoff- und Textilpolymeren, hat die Veröffentlichung
Poxel to Report its 2022 Full Year Results by the End of March 2023
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic
A New Prestigious Scientific Publication for Carbios Marks the Expansion of Its Research to Other Plastics
Regulatory News:
Carbios (Euronext Growth Paris: ALCRB) (Paris:ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and